USANA Health Sciences Files Q2 2024 10-Q
Ticker: USNA · Form: 10-Q · Filed: 2024-08-06T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, health-sciences
TL;DR
USANA Health Sciences dropped its Q2 2024 10-Q, check financials.
AI Summary
USANA Health Sciences Inc. filed its 10-Q for the period ending June 29, 2024. The filing details financial performance and operational updates for the second quarter of 2024. Key financial figures and business segments are presented, reflecting the company's ongoing activities in the health sciences sector.
Why It Matters
This filing provides investors and analysts with the latest financial health and performance data for USANA Health Sciences, crucial for understanding the company's trajectory and making informed investment decisions.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the health sciences sector can be subject to regulatory and market risks.
Key Numbers
- 20240629 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
- 20240806 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- USANA HEALTH SCIENCES INC (company) — Filer of the 10-Q report
- 20240629 (date) — End of the reporting period
- SALT LAKE CITY (location) — Company's business and mailing address city
- UT (location) — Company's business and mailing address state
- 8019547100 (phone_number) — Company's business phone number
FAQ
What is the primary business of USANA Health Sciences Inc. as indicated by its SIC code?
USANA Health Sciences Inc. is classified under SIC code 2833, which corresponds to 'MEDICINAL CHEMICALS & BOTANICAL PRODUCTS'.
What is the fiscal year end for USANA Health Sciences Inc.?
The fiscal year end for USANA Health Sciences Inc. is December 28.
What is the SEC file number for USANA Health Sciences Inc.?
The SEC file number for USANA Health Sciences Inc. is 001-35024.
What is the state of incorporation for USANA Health Sciences Inc.?
USANA Health Sciences Inc. is incorporated in Utah (UT).
What was the previous name of USANA Health Sciences Inc. and when did the name change occur?
The former company name was USANA INC, and the date of the name change was January 25, 1993.
From the Filing
0000896264-24-000208.txt : 20240806 0000896264-24-000208.hdr.sgml : 20240806 20240806124241 ACCESSION NUMBER: 0000896264-24-000208 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 59 CONFORMED PERIOD OF REPORT: 20240629 FILED AS OF DATE: 20240806 DATE AS OF CHANGE: 20240806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 241178156 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 10-Q 1 usna-20240629.htm 10-Q usna-20240629 0000896264 12/28 2024 Q2 false xbrli:shares iso4217:USD iso4217:USD xbrli:shares usna:region xbrli:pure usna:segment 0000896264 2023-12-31 2024-06-29 0000896264 2024-08-02 0000896264 2024-06-29 0000896264 2023-12-30 0000896264 2024-03-31 2024-06-29 0000896264 2023-04-02 2023-07-01 0000896264 2023-01-01 2023-07-01 0000896264 us-gaap:CommonStockMember 2022-12-31 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2022-12-31 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000896264 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2023-01-01 2023-07-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-07-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-07-01 0000896264 us-gaap:CommonStockMember 2023-01-01 2023-07-01 0000896264 us-gaap:CommonStockMember 2023-07-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 0000896264 us-gaap:RetainedEarningsMember 2023-07-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 0000896264 2023-07-01 0000896264 us-gaap:CommonStockMember 2023-12-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-12-30 0000896264 us-gaap:RetainedEarningsMember 2023-12-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-30 0000896264 us-gaap:RetainedEarningsMember 2023-12-31 2024-06-29 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 2024-06-29 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 2024-06-29 0000896264 us-gaap:CommonStockMember 2023-12-31 2024-06-29 0000896264 us-gaap:CommonStockMember 2024-06-29 0000896264 us-gaap:AdditionalPaidInCapitalMember 2024-06-29 0000896264 us-gaap:RetainedEarningsMember 2024-06-29 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-29 0000896264 us-gaap:CommonStockMember 2023-04-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 0000896264 us-gaap:RetainedEarningsMember 2023-04-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 0000896264 2023-04-01 0000896264 us-gaap:RetainedEarningsMember 2023-04-02 2023-07-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-02 2023-07-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-04-02 2023-07-01 0000896264 us-gaap:CommonStockMember 2023-04-02 2023-07-01 0000896264 us-gaap:CommonStockMember 2024-03-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2024-03-30 0000896264 us-gaap:RetainedEarningsMember 2024-03-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-30 0000896264 2024-03-30 0000896264 us-gaap:RetainedEarningsMember 2024-03-31 2024-06-29 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 2024-06-29 0000896264 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 2024-06-29 0000896264 us-gaap:CommonStockMember 2024-03-31 2024-06-29 0000896264 us-gaap:FairValueMeasurementsR